US FDA Sets 'Low Bar' For Meetings With Patients
New request system is intended to boost FDA transparency, allow patients to more easily gain access to agency staff.
You may also be interested in...
US FDA's drug center has been hiring more employees than it has lost over the last few months and hopes the Office of New Drugs reorganization will help retention.
Reorganization also may force change to commissioner succession plan.
Agency's agreement with rare disease advocacy group will facilitate patient meetings with review divisions, as well as enhance communication of safety information.